Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Florida Cancer Specialists, Sarasota, Florida Tennessee Oncology, Nashville, Tennessee NEXT Oncology, Fairfax, Virginia South Korea
Severance Hospital Yonsei University Health System, Seoul Samsung Medical Center, Seoul Spain
Hosp Univ Vall D Hebron, Barcelona Hosp Univ Fund Jimenez Diaz, Madrid Hosp. Univ. 12 de Octubre, Madrid Hosp Univ Hm Sanchinarro, Madrid